348 related articles for article (PubMed ID: 32041784)
1. Reconstitution of Circulating Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Cell Transplantation: Its Association with the Riboflavin Synthetic Pathway of Gut Microbiota in Cord Blood Transplant Recipients.
Konuma T; Kohara C; Watanabe E; Takahashi S; Ozawa G; Suzuki K; Mizukami M; Nagai E; Jimbo K; Kaito Y; Isobe M; Kato S; Takahashi S; Chiba A; Miyake S; Tojo A
J Immunol; 2020 Mar; 204(6):1462-1473. PubMed ID: 32041784
[TBL] [Abstract][Full Text] [Related]
2. The Potential Roles of Mucosa-Associated Invariant T Cells in the Pathogenesis of Gut Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation.
Gao MG; Hong Y; Zhao XY; Pan XA; Sun YQ; Kong J; Wang ZD; Wang FR; Wang JZ; Yan CH; Wang Y; Huang XJ; Zhao XS
Front Immunol; 2021; 12():720354. PubMed ID: 34539656
[TBL] [Abstract][Full Text] [Related]
3. Mucosal-associated invariant T-Cell (MAIT) activation is altered by chlorpyrifos- and glyphosate-treated commensal gut bacteria.
Mendler A; Geier F; Haange SB; Pierzchalski A; Krause JL; Nijenhuis I; Froment J; Jehmlich N; Berger U; Ackermann G; Rolle-Kampczyk U; von Bergen M; Herberth G
J Immunotoxicol; 2020 Dec; 17(1):10-20. PubMed ID: 31909636
[TBL] [Abstract][Full Text] [Related]
4. Influence of post-transplant mucosal-associated invariant T cell recovery on the development of acute graft-versus-host disease in allogeneic bone marrow transplantation.
Kawaguchi K; Umeda K; Hiejima E; Iwai A; Mikami M; Nodomi S; Saida S; Kato I; Hiramatsu H; Yasumi T; Nishikomori R; Kondo T; Takaori-Kondo A; Heike T; Adachi S
Int J Hematol; 2018 Jul; 108(1):66-75. PubMed ID: 29582333
[TBL] [Abstract][Full Text] [Related]
5. Graft-Derived Reconstitution of Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Cell Transplantation.
Bhattacharyya A; Hanafi LA; Sheih A; Golob JL; Srinivasan S; Boeckh MJ; Pergam SA; Mahmood S; Baker KK; Gooley TA; Milano F; Fredricks DN; Riddell SR; Turtle CJ
Biol Blood Marrow Transplant; 2018 Feb; 24(2):242-251. PubMed ID: 29024803
[TBL] [Abstract][Full Text] [Related]
6. Unconventional T Cells Influence Clinical Outcome After Allogeneic Hematopoietic Cell Transplantation.
Siblany L; Stocker N; Ricard L; Brissot E; Duléry R; Banet A; Sestili S; Belhocine R; Van de Wyngaert Z; Bonnin A; Capes A; Ledraa T; Beurier P; Fadel K; Mohty M; Gaugler B; Malard F
J Clin Immunol; 2024 Jun; 44(6):139. PubMed ID: 38822857
[TBL] [Abstract][Full Text] [Related]
7. Recipient mucosal-associated invariant T cells control GVHD within the colon.
Varelias A; Bunting MD; Ormerod KL; Koyama M; Olver SD; Straube J; Kuns RD; Robb RJ; Henden AS; Cooper L; Lachner N; Gartlan KH; Lantz O; Kjer-Nielsen L; Mak JY; Fairlie DP; Clouston AD; McCluskey J; Rossjohn J; Lane SW; Hugenholtz P; Hill GR
J Clin Invest; 2018 May; 128(5):1919-1936. PubMed ID: 29629900
[TBL] [Abstract][Full Text] [Related]
8. Stool Microbiota at Neutrophil Recovery Is Predictive for Severe Acute Graft vs Host Disease After Hematopoietic Cell Transplantation.
Golob JL; Pergam SA; Srinivasan S; Fiedler TL; Liu C; Garcia K; Mielcarek M; Ko D; Aker S; Marquis S; Loeffelholz T; Plantinga A; Wu MC; Celustka K; Morrison A; Woodfield M; Fredricks DN
Clin Infect Dis; 2017 Nov; 65(12):1984-1991. PubMed ID: 29020185
[TBL] [Abstract][
